FMN exhibited significant effects in alleviating hypothalamic inflammation, with its potential mechanism involving the downregulation of the central NF‐κB signaling pathway, thereby further mitigating metabolic disorders. This evidence concerns the gene NFKB1 and Other metabolic disease.